# Bristol-Myers Squibb Company (BMY) — Q1-2024 Earnings Results

**Report date:** 2024-04-25 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q1-2024

## Post-Earnings Brief

### Headline

Bristol-Myers Squibb Misses on EPS, Stock Down 8.51%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-4.40 | N/A | -387.21% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record, and the analysis is based on numerical results only.

### Guidance Changes

No forward guidance data is available.

### What It Means

Bristol-Myers Squibb reported a significant loss in EPS, which contributed to an 8.51% decline in stock price. The lack of revenue data and guidance leaves investors uncertain about the company's future performance. The large EPS miss suggests potential challenges that may need to be addressed in upcoming quarters.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q1-2024_